Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial

JOURNAL ARTICLE published January 2017 in The Lancet

Authors: Arjun V Balar | Matthew D Galsky | Jonathan E Rosenberg | Thomas Powles | Daniel P Petrylak | Joaquim Bellmunt | Yohann Loriot | Andrea Necchi | Jean Hoffman-Censits | Jose Luis Perez-Gracia | Nancy A Dawson | Michiel S van der Heijden | Robert Dreicer | Sandy Srinivas | Margitta M Retz | Richard W Joseph | Alexandra Drakaki | Ulka N Vaishampayan | Srikala S Sridhar | David I Quinn | Ignacio Durán | David R Shaffer | Bernhard J Eigl | Petros D Grivas | Evan Y Yu | Shi Li | Edward E Kadel | Zachary Boyd | Richard Bourgon | Priti S Hegde | Sanjeev Mariathasan | AnnChristine Thåström | Oyewale O Abidoye | Gregg D Fine | Dean F Bajorin